Results 1 to 10 of about 718,829 (184)
Knowledge, attitude, and practice towards insulin therapy in type 2 diabetes: an insight from Ethiopian context [PDF]
BMC Primary CareBackground As type 2 diabetes is a growing health problem worldwide, targeting an early treatment and intensification of therapy will decrease the associated morbidity and mortality as evidenced by large trials.
Biniyam Woya Sheno +2 more
doaj +2 more sources
Insulin resistance and iatrogenic hyperinsulinemia in type 1 diabetes - norm or complication? Role of metformin in type 1 diabetes mellitus [PDF]
Acta Poloniae Pharmaceutica, 2023 There is a rising trend of overweight and obesity among individuals with type 1 diabetes. This is often associated with decreased insulin sensitivity, increased insulin dose requirements and poor glycemic control.
Małgorzata Bekier +2 more
doaj +1 more source
Frontiers in Cardiovascular Medicine, 2021 Background: Controversies concerning the association between insulin therapy and atherosclerotic lesions in type 2 diabetes mellitus (T2DM) remain to exist.
Jiang-Feng Ke +5 more
doaj +1 more source
Issues of insulin therapy for type 2 diabetes and ways to solve them
Mìžnarodnij Endokrinologìčnij Žurnal, 2023 The article is a summary of personal experience and literature data from PubMed, Scopus, Web of Science, ClinicalTrials.gov databases. As a result of the analysis, the main problems faced by practical endocrinologists when administering insulin therapy ...
V.I. Katerenchuk, A.V. Katerenchuk
doaj +1 more source
New Insulins and Insulin Therapy [PDF]
Diabetes Technology & Therapeutics, 2013 The introduction of the so-called 'designer' insulins, the insulin analogues, has offered new opportunities in the clinical management of diabetes. Two additional new entities are close to reaching clinical practice. Linjeta™ (formally called VIAject) is not an analogue but rather a different formulation of human insulin which may give it a more rapid ...
Jan, Bolinder, Thomas, Danne
openaire +6 more sources
Frontiers in Endocrinology, 2023 IntroductionThe purpose of this retrospective clinic chart review study was to determine the potential of a combination therapy (CT) consisting of γ-aminobutyric acid (GABA), a dipeptidyl peptidase-4 inhibitor (DPP-4i), and a proton pump inhibitor (PPI ...
Alexander Rabinovitch +9 more
doaj +1 more source
Type 1 diabetes mellitus in chronic insulin deficiency conditions
Медицинский вестник Юга России, 2021 Mauriac syndrome is a severe complication of type 1 diabetes mellitus, manifested by growth retardation, impaired formation of secondary sexual characteristics, lack of libido, and hepatomegaly. Currently, the presented syndrome is quite rare.
A. Yu. Surovtseva +2 more
doaj +1 more source
BMC Endocrine Disorders, 2020 Background The risk of surgical site infection has been reported to be higher in patients with poorly controlled diabetes. Since chronic hyperglycemia impairs neutrophil functions, preoperative glycemic control may restore neutrophil function.
Daichi Fujimoto +4 more
doaj +1 more source
Clinical Diabetology, 2023 OBJECTIVE: The authors aimed to identify risk factors for insulin therapy need and for the development of postpartum prediabetes in women with gestational diabetes mellitus (GDM).
Magdalena Dolecka-Ślusarczyk +5 more
doaj +1 more source
A greater proportion of participants with type 2 diabetes achieve treatment targets with insulin degludec/liraglutide versus insulin glargine 100 units/mL at 26 weeks. DUAL VIII, a randomized trial designed to resemble clinical practice [PDF]
, 2020 This report presents the efficacy and safety of insulin degludec/liraglutide (IDegLira) versus insulin glargine 100 units/mL (IGlar U100) as initial injectable therapy at 26 weeks in the 104-week DUAL VIII durability trial (NCT02501161). Participants (N =
Aroda, V. R. +7 more
core +1 more source